| Literature DB >> 19765298 |
Timm Konold1, John Spiropoulos, Melanie J Chaplin, Leigh Thorne, Yvonne I Spencer, Gerald A H Wells, Steve A C Hawkins.
Abstract
BACKGROUND: Histopathological examinations of brains from healthy pigs have revealed localised vacuolar changes, predominantly in the rostral colliculus, that are similar to the neuropil vacuolation featured in the transmissible spongiform encephalopathies and have been described in pigs challenged parenterally with the agent causing bovine spongiform encephalopathy (BSE). Feedstuff containing BSE-contaminated meat and bone meal (MBM) may have been fed to pigs prior to the ban of mammalian MBM in feed of farmed livestock in the United Kingdom in 1996, but there is no evidence of the natural occurrence of a transmissible spongiform encephalopathy (TSE) in the domestic pig. Furthermore, experimental transmission of BSE to pigs by the oral route has been unsuccessful. A study was conducted to investigate whether the localised vacuolar changes in the porcine brain were associated with a transmissible aetiology and therefore biologically significant. Two groups of ten pigs were inoculated parenterally with vacuolated rostral colliculus from healthy pigs either born before 1996 or born after 1996. Controls included ten pigs similarly inoculated with rostral colliculus from New Zealand-derived pigs and nine pigs inoculated with a bovine BSE brain homogenate.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19765298 PMCID: PMC2761866 DOI: 10.1186/1746-6148-5-35
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Individual animal details and pathological status of the pigs used in the study
| PR459 | None | F | N/Aa | Intercurrent death (arthrosis) | -/-/- |
| PR471 | Pre-1996 | M | 250 | Intercurrent death (foot abscess) | -/-/- |
| PR486 | Pre-1996 | F | 265 | Killed at termination of study | -/-/- |
| PR484 | Pre-1996 | M | 277 | Intercurrent death (arthrosis & spondylosis) | -/-/- |
| PR470 | Pre-1996 | M | 295 | Killed at termination of study | -/-/- |
| PR472 | Pre-1996 | M | 295 | Killed at termination of study | -/-/- |
| PR475 | Pre-1996 | F | 295 | Killed at termination of study | -/-/- |
| PR478 | Pre-1996 | F | 295 | Killed at termination of study | -/-/- |
| PR482 | Pre-1996 | F | 295 | Killed at termination of study | -/-/- |
| PR467 | Pre-1996 | M | 297 | Killed at termination of study | -/-/- |
| PR469 | Pre-1996 | M | 297 | Killed at termination of study | -/-/- |
| PR477 | Post-1996 | F | 209 | Intercurrent death (cause undetermined) | -/-/- |
| PR480 | Post-1996 | M | 250 | Intercurrent death (tumour) | -/-/- |
| PR488 | Post-1996 | M | 255 | Intercurrent death (foot abscess) | -/-/- |
| PR468 | Post-1996 | M | 295 | Killed at termination of study | -/-/- |
| PR479 | Post-1996 | M | 296 | Killed at termination of study | -/-/- |
| PR481 | Post-1996 | M | 296 | Killed at termination of study | -/-/- |
| PR483 | Post-1996 | F | 296 | Killed at termination of study | -/-/- |
| PR487 | Post-1996 | F | 296 | Killed at termination of study | -/-/- |
| PR474 | Post-1996 | M | 299 | Killed at termination of study | -/-/- |
| PR476 | Post-1996 | F | 299 | Killed at termination of study | -/-/- |
| PR463 | BSE | M | 148 | Recumbency | +/+/+ |
| PR443 | BSE | F | 175 | Recumbency | +/+/+ |
| PR445 | BSE | F | 234 | Arthrosis | -/-/- |
| PR442 | BSE | F | 294 | Killed at termination of study | -/-/-b |
| PR441 | BSE | M | 294 | Killed at termination of study | -/-/- |
| PR444 | BSE | F | 294 | Killed at termination of study | -/-/-b |
| PR462 | BSE | M | 297 | Killed at termination of study | -/-/- |
| PR460 | BSE | F | 297 | Killed at termination of study | -/-/- |
| PR440 | BSE | M | 298 | Killed at termination of study | -/-/-b |
| PR620 | NZ-brain | F | 17 | Fracture of right femur | -/-/- |
| PR593 | NZ-brain | F | 84 | Spinal abscess | -/-/- |
| PR596 | NZ-brain | M | 218 | Arthritis | -/-/- |
| PR591 | NZ-brain | F | 275 | Killed at termination of study | -/-/- |
| PR594 | NZ-brain | F | 275 | Killed at termination of study | -/-/- |
| PR598 | NZ-brain | M | 275 | Killed at termination of study | -/-/- |
| PR599 | NZ-brain | F | 275 | Killed at termination of study | -/-/- |
| PR621 | NZ-brain | F | 276 | Killed at termination of study | -/-/- |
| PR623 | NZ-brain | F | 276 | Killed at termination of study | -/-/- |
| PR627 | NZ-brain | M | 276 | Killed at termination of study | -/-/- |
N/A Not applicable
HP Histopathology
F Female
M Male (castrated)
a Culled at 231 weeks of age.
b Neuropathological examination extended to representation of all brain regions.
Presence of selected TSE-like clinical signs or combination of signs observed at the pre-cull assessment
| Repeatable over-reactivity to menace testing | 2 | 6 | 2 | 0 | ns | ns | 0.0031 |
| Apprehension towards observer | 0 | 5 | 0 | 1 | 0.01 | 0.01 | ns |
| Repeatable over-reactivity to probing of the neck | 1 | 7 | 1 | 1 | 0.006 | 0.006 | 0.006 |
| Stiff gait | 0 | 4 | 3 | 0 | 0.033 | ns | 0.033 |
| Ataxia | 0 | 5 | 0 | 1 | 0.01 | 0.01 | 0.0498 |
| Apprehension, over-reactivity & ataxia/stiff gait | 0 | 5 | 0 | 0 | 0.0108 | 0.0108 | 0.0108 |
| Apprehension & over-reactivity | 0 | 5 | 0 | 0 | 0.0108 | 0.0108 | 0.0108 |
| Apprehension & ataxia/stiff gait* | 0 | 5 | 0 | 1 | 0.0108 | 0.0108 | ns |
| Over-reactivity & ataxia/stiff gait* | 0 | 8 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 |
The numbers in the first four columns (groups A-D) refer to the number of animals displaying this particular sign or combination of signs. Columns 5-7 list the P value by group comparison; ns = not significant (P > 0.05).
Group A = NZ brain, includes pig that was not inoculated (N = 10)
Group B = BSE (N = 9)
Group C = Pre-1996 group (N = 10)
Group D = Post-1996 group (N = 10)
* Signs associated with a prion disease; the one animal in group D with multiple abscesses is listed for completeness although a prion disease was not suspected (see text).
Figure 1Disease-specific immunolabelling in a BSE-inoculated pig. Serial coronal sections (A and B) of rostral midbrain (periaqueductal grey matter) of pig PR443. A) Specific immunolabelling in neuronal perikarya and neuropil. Immunolabelling with mAb 2G11. B) Specific immunolabelling in neuronal perikarya and neuropil, masked to some extent compared to A) due to non-specific background immunolabelling with mAb L42. Scale bars: 50 μm.
Figure 2Absence of disease-specific immunolabelling in an un-inoculated pig. Serial coronal sections (A and B) of rostral midbrain (oculomotor nerve nucleus) of pig PR459. A) Absence of any labelling. Immunolabelling with mAb 2G11. B) Presence of disease-unspecific labelling of neuronal perikarya with mAb L42.
Figure 3Disease-unspecific, antibody-related immunolabelling in a BSE-inoculated pig presenting neurological signs in the absence of pathological evidence of disease. Serial coronal sections (A and B) of rostral midbrain (oculomotor nerve nucleus) of pig PR442. A) No evidence of PrPd immunolabelling with mAb 2G11. B) Presence of ubiquitous disease-unspecific labelling of neuronal perikarya experienced in pig brain with mAb L42. Scale bars: 50 μm.
Figure 4Western immunoblot of caudal medulla of selected pigs from each group.
Lanes
1 Biotinylated molecular mass marker
No PK PK+ Animal ID
2 8 BSE group (positive) - PR463
3 9 BSE group (positive) - PR443
4 11 Pre-1996 group (negative) - PR469
5 12 Post-1996 group (negative) - PR476
6 13 BSE group (negative, clinical suspect) - PR442
7 14 Un-inoculated pig (negative) - PR459
10 NZ-brain (negative) - PR591
15 Bovine BSE positive control
16 Ovine scrapie positive control
VLA Hybrid technique (discriminatory WB) using core mAb, 6H4 (Figure A), and 'N' terminal mAbs, P4 (Figure B) and 12B2 (Figure C), to distinguish scrapie from BSE. Treatment with and without PK was used to visualise PrPres and PrPc respectively.
EIA result on thalamic samples of selected pigs
| PR463 (BSE) | 2.86 | 2.926 | Positive |
| PR442 (BSE) | 0.03 | 0.029 | Negative |
| PR469 (Pre-1996) | 0.03 | 0.032 | Negative |
| PR476 (Post-1996) | 0.022 | 0.022 | Negative |
| PR591 (NZ brain) | 0.032 | 0.027 | Negative |
OD Optical density